Searchable abstracts of presentations at key conferences in endocrinology

ea0063p778 | Thyroid 2 | ECE2019

Graves’ disease: woman or man, is there a difference in clinical presentation or evolution?

Chermiti Sondes , Hasni Yosra , Bayar Ines , Abdelkarim Asma , Kacem Maha , Chaieb Molka , Maaroufi Amel , Ach Koussay

Grave’s disease (GD), like all autoimmune diseases, is predominantly female, with sex ratio to 3 women for one man. The treatment of first intension is based on antithyroid drugs (ATD). Our objective is to compare the clinical presentation and the evolution of GD by gender. It’s a retrospective study. We studied patients with a first diagnosis of GD, in the department of endocrinology in Farhat Hached hospital in Susah, between Juanuary 2010 and December 2015. The pa...

ea0099ep1156 | Pituitary and Neuroendocrinology | ECE2024

Hyperprolactinemia: a rare association between primary hypothyroidism and macroprolactinoma

Sassi Eya , Chermiti Sondes , Zitoun Bochra , Marzouk Hajer , Kharrat Issam , Hasni Yosra , Debbabi Wided

Introduction: Primary hypothyroidism is a common cause of hyperprolactinemia. TSH measurement is part of the first-line investigation of hyperprolactinemia wich usually disappear after L-thyroxine therapy. the presence of pituitary hyperplasia mimicking a pituitary macroadenoma has been reported by several authors, but coexistence oh primary hypothyroidism and prolactinoma is rarely reported.Case: We report a rare case of hyperprolactinemia revealing the...

ea0063p779 | Thyroid 2 | ECE2019

Medical treatment of Gaves’ disease in Tunisia: comparison of Methimazole and Benzylthiouracil

Hasni Yosra , Chermiti Sondes , El Fekih Hamza , Ben Abdelkarim Asma , Kacem Maha , Chaieb Molka , Maaroufi Amel , Ach Koussay

Background: Antithyroid drugs (ATD) are indicated as first intension in the treatment of Graves’disease (GD). Only two molecules are marketed in Tunisia: Benzylthiouracil (BTU) and Methimazole (MMI). There is still no clear conclusion about the choice of appropriate drug. Our objective was to compare the MMI treatment with the BTU in terms of efficacy and adverse effects (AEs).Methods: It’s a retrospective study. We studied patients with a firs...

ea0063p1086 | Pituitary and Neuroendocrinology 3 | ECE2019

Predictive factors of surgical outcomes in acromegaly

Wafa Badr , Hasni Yosra , Chermiti Sondes , Abdelkarim Asma Ben , Kacem Maha , Chaieb Molka , Maaroufi Amel , Ach Koussay

Introduction: Acromegaly is a chronic disorder usually caused by growth hormone (GH)-secreting pituitary adenomas. Transsphenoidal surgery remains a treatment of choice for restoring GH to normal levels. The aim of this study was to illustrate the relationship between some factors and transsphenoidal surgery outcomes.Patients and methods: We retrospectively analysed the outcome of 31 patients with acromegaly after initial endoscopic transsphenoidal surge...